Clinical Trials Browser

Phase 3 × Recruiting × Dermatologic × Clear all

NCT06568172 2026-04-16

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Phase 3 Recruiting

DermatologicHead & NeckSarcoma

Eyelid Squamous Cell Carcinoma

NCT07530887 2026-04-15

NORMA-2

Phase 3 Recruiting

Melanoma

NCT02821013 2026-04-14

STOP-GAP

Phase 3 Recruiting

Melanoma

NCT06743126 2026-04-13

SUPRAME

Phase 3 Recruiting

Melanoma, Cutaneous Malignant

NCT06585410 2026-04-08

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Phase 3 Recruiting

Skin Neoplasms

NCT05727904 2026-04-03

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Phase 3 Recruiting

Melanoma, Skin Neoplasms

NCT06470451 2026-04-03

FLASH2

Phase 3 Recruiting

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT06500455 2026-04-03

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Phase 3 Recruiting

BreastCNSDermatologicGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT06246149 2026-03-04

ATOM

Phase 3 Recruiting

Uveal Melanoma

NCT06007690 2026-03-02

CoMpass

Phase 3 Recruiting

Uveal Melanoma, Eye Neoplasms

NCT05549297 2026-02-25

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Phase 3 Recruiting

Melanoma, Nevus, Blue

NCT06246916 2026-02-19

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Phase 3 Recruiting

Melanoma

NCT07015190 2026-02-18

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Phase 3 Recruiting

Uveal Melanoma, Melanoma

NCT07381972 2026-02-02

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma

Phase 3 Recruiting

Nodular Basal Cell Carcinoma of Skin

NCT07221734 2026-01-21

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

Phase 3 Recruiting

Melanoma, Neoplasm Metastasis

NCT03567889 2025-12-17

NeoDREAM

Phase 3 Recruiting

Melanoma

NCT06794775 2025-12-12

SWE-NEO

Phase 3 Recruiting

Melanoma

NCT05522660 2025-12-11

USZ-STRIKE

Phase 3 Recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07137819 2025-08-22

EXACT-1

Phase 3 Recruiting

Keratosis, Actinic

NCT05868707 2025-07-25

OH2 Injection in Melanoma

Phase 3 Recruiting

Melanoma

NCT05078047 2025-06-05

MOIO

Phase 3 Recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Esophageal Squamous Cell Carcinoma, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05502900 2025-05-15

AMUM

Phase 3 Recruiting

Uveal Melanoma

NCT05899465 2025-03-18

PRIME

Phase 3 Recruiting

Melanoma, Neoplasms, Recurrence

NCT05955924 2025-02-21

SPRINTR

Phase 3 Recruiting

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT05634252 2024-12-13

RISE-UP

Phase 3 Recruiting

Skin Neoplasms, Sunburn

NCT06519266 2024-11-25

SCANDIUM-III

Phase 3 Recruiting

Uveal Melanoma

NCT06008106 2024-06-28

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

Phase 3 Recruiting

Melanoma